DCMTSA对创伤性股骨头坏死大鼠BMP-2和BMP-7表达的影响
[Abstract]:Background fracture healing is a complex biological repair process, the clinical delayed healing / non-union problem remains unresolved, the traditional Chinese and western medicine intervention treatment time is long, the effect is not ideal. At present, bone morphogenetic protein is the best cytokine to promote fracture healing. It was found that bone morphogenetic protein could induce bone marrow stromal cells to differentiate into osteoblasts. Sodium alginate (sodium alginate,SA) is a kind of natural polysaccharide polymer extracted from brown algae. The biocompatibility of SA can be improved if the hydroxyl group of part of SA uronic acid unit is converted into aldehyde group, that is, carboxymethyl alginate sodium (dicarboxmethyl trisodium alignate,DCMTSA. It can be used as an effective drug to induce bone morphogenetic protein. Objective to improve the biological characteristics of SA, to investigate the effect of DCMTSA on the expression of bone morphogenetic protein, to clarify the effect of DCMTSA on the differentiation of bone marrow stromal cells into osteoblasts, and to provide a simple preparation method. A wide range of raw materials for the treatment and prevention of fracture drugs, for clinical prevention and treatment of fracture and other diseases to provide laboratory basis. Methods (1) DCMTSA:SA was partially oxidized by hydrogen peroxide solution or potassium permanganate, and the hydroxyl groups of some uronic acid units were transformed into aldehydes, which improved the biocompatibility of SA. SD rats aged 2-3 months were made into traumatic femoral head necrosis model and were randomly divided into three groups with 15 rats in each group. The rats in the DCMTSA group were given DCMTSA 0.1 g.kg-1.d-1 daily. SA group, rats were fed with SA 0.1g.kg-1.d-1 daily; Rats in control group were treated with 0.1g.kg-1.d-1 normal saline daily. 3 Experimental methods: 5 rats in each group died at 14 days and 21 days after operation respectively. The femur of rat fracture was divided into two parts: one was decalcified after 10% formaldehyde fixation, the structure of callus growth was observed under light microscope with HE staining, and bone morphogenetic protein-2 (bone morphogenetie protein-2, was detected by immunohistochemical SP method. The expression of bone morphogenetic protein-7 (bone morphogenetie protein-7,BMP-7 (BMP-2); After decalcification and softening, the expression of BMP-2 mRNA and BMP-7 mRNA was detected by RT-PCR. Results 1 the results of HE staining showed that the fibrous tissue proliferation, trabecular formation, bone matrix formation and bone structure formation in the DCMTSA group were significantly better than those in the SA group. SA group was superior to control group. 2 Immunohistochemical results showed that the expression of BMP-2 and BMP-7 protein in DCMTSA group was higher than that in SA group, and that in SA group was higher than that in SA group. 3 the results of RT-PCR detection in SA group were higher than those in control group: 21 days after operation, 21 days after operation, the expression of BMP-2 and BMP-7 protein in three groups was higher than in SA group. The expression of BMP-2 and BMP-7 protein mRNA in DCMTSA group was higher than that in SA group, and that in SA group was higher than that in control group. 4 the average trabecular bone count, mean trabecular thickness and mean trabecular area in DCMTSA group were higher than those in SA group 21 days after operation. The SA group was larger than the control group. In the control group, the volume of cancellous bone and dense bone decreased significantly, the number of trabecular bone decreased, the medullary cavity enlarged, and the thickness of trabecular bone and cortical bone thinned. Conclusion DCMTSA can promote the release of BMP-2 and BMP-7 from bone tissue cells more than SA, can promote osteoblast differentiation and inhibit bone resorption caused by osteoclasts, which is beneficial to bone healing in rats with traumatic osteonecrosis of femoral head.
【学位授予单位】:新乡医学院
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R683
【参考文献】
相关期刊论文 前10条
1 刘泽汉;王立春;张宏颖;公伟勋;荆鹏伟;陈琳;何旭;;动物脂肪干细胞联合双重转化生长因子释放支架修复关节软骨损伤的实验研究[J];中国骨与关节损伤杂志;2012年12期
2 张新宽;赵京生;刘英杰;柴青芬;许佳平;;四法疏经法治疗股骨头缺血性坏死的临床研究[J];光明中医;2014年02期
3 刘国岩;徐琬梨;张世华;;活血补髓汤治疗激素性股骨头坏死的实验研究[J];江西中医药;2014年02期
4 王平,高红艳;辨证分型治疗激素型股骨头坏死117例[J];上海中医药大学学报;2003年01期
5 章恒;曾明珠;冯强;;补肾活血方联合银质针导热治疗早中期股骨头坏死临床研究[J];新中医;2014年02期
6 司艳莉;李冬霞;刘友才;千智斌;;海藻酸多糖衍生物治疗大鼠骨质疏松(英文)[J];中国组织工程研究与临床康复;2011年24期
7 林永城;曾炎辉;张泽玫;;补肾复活汤对中老年股骨头缺血性坏死患者血液流变学的影响[J];中国康复;2007年01期
8 黄自冲;;固附汤治疗股骨头坏死[J];中国民间疗法;2009年07期
9 孙缨;张碧霞;王玲;;硝苯地平-海藻酸钠缓释片的制备和性能研究[J];中南药学;2012年04期
10 顾晓东;李雪;;纳米羟基磷灰石/胶原蛋白复合骨结合血管内皮生长因子/骨形态发生蛋白-7修复骨缺损的实验研究[J];中国医药指南;2013年28期
相关博士学位论文 前1条
1 毕锴;中医骨折分期治疗对骨折愈合bFGF、TGF-β、VEGF、BMP-2基因表达影响的实验研究[D];中国中医科学院;2013年
,本文编号:2327378
本文链接:https://www.wllwen.com/yixuelunwen/waikelunwen/2327378.html